CCO Independent Conference Coverage at NLA and ADA 2023: New Data and Clinical Integration of Therapies Approved for Dyslipidemia *

Engage in scientific analysis of data presented at NLA and ADA 2023, with expert post-conference analysis, including Capsule Summaries on key lipid and cardiovascular prevention and treatment studies. Watch the Expert on the Ground video summaries, download the slides, and gain actionable insight through ClinicalThought commentaries.

Share

Program Content

Activities

Very-High Risk ASCVD With CAC ≥1000
Prognostic Markers of Very-High Risk ASCVD in Persons With CAC ≥1000
Capsule Summary
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

CLEAR Outcomes
CLEAR Outcomes: Bempedoic Acid Reduces Risk of Major Cardiovascular Event vs Placebo in Statin-Intolerant Patients
Capsule Summary
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2023

ROSE2
ROSE2: Phase II Trial of Obicetrapib + Ezetimibe as an Adjunct to High-Intensity Statin Therapy
Capsule Summary
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2023

NLA 2023 Key Takeaways
Expert Analysis and Conference Coverage of NLA 2023
Conference Coverage
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2023

Expires: June 08, 2024

NLA Pearls 2023
An Expert’s Guide to National Lipid Association 2023: Pearls and Takeaways
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2023

Activities

CLEAR Outcomes ADA
CLEAR Outcomes: LDL Cholesterol Reduction and Cardiovascular Outcomes With Bempedoic Acid in High-Risk Primary Prevention Patients
Capsule Summary
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2023

Combination SGLT2is/GLP-1 RAs
Prescription Rates for SGLT2 Inhibitors and GLP-1 Receptor Agonists at Discharge and 1 Yr Later in Persons With T2D and Index MI
Capsule Summary
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2023

CINEMA Program
CINEMA: 2-Yr Follow-up of a Multidisciplinary Risk Factor Reduction Strategy for Patients With Type 2 Diabetes at Increased CV Risk
Capsule Summary
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 28, 2023

ADA 2023 Key Takeaways
Expert Analysis and Conference Coverage of ADA 2023
Conference Coverage
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 03, 2023

Expires: July 02, 2024

ADA 2023
An Expert’s Guide to ADA 2023: Pearls and Takeaways
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2023

Faculty

cover img faculity

Payal Kohli, MD, FACC

Associate Adjunct Professor in Cardiology Division, Department of Medicine, Duke University
Associate Clinical Professor of Medicine, University of Colorado Anshutz
Founder and Medical Director, Cherry Creek Heart
On-Air Medical Expert, Tegna Broadcasting
Aurora, Colorado

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.